BioSig Technologies, Inc.BSGM
...Loading BSGM Peers...
BioSig Technologies, Inc., together with its subsidiaries, operates as medical device company. The company's proprietary product includes precise uninterrupted real-time evaluation of electrograms electrophysiology (PURE EP) system, a signal processing platform that combines hardware and software to address known challenges associated to signal acquisition that enables electrophysiologists to see signals and analyze in real-time. It also focuses on enhancing intracardiac signal acquisition and diagnostic information for the procedures of atrial fibrillation, as well as is designed to address long-standing limitations that slow and disrupt cardiac catheter ablation procedures. The company has a research agreement with University of Minnesota to develop novel therapies to treat sympathetic nervous system diseases; and a strategic collaboration with the Mayo Foundation for Medical Education and Research to develop an AI-and machine learning software solution for PURE EP systems. BioSig Technologies, Inc. was incorporated in 2009 and is headquartered in Westport, Connecticut.
4 Employees
CEO : Mr. Anthony Amato
Address : 55 Greens Farms Road, Westport,CT, US, - 06880,
Key Excutives | Designation |
---|---|
Mr. Anthony Amato | Chief Executive Officer, Chairman & Member of Advisory Board |
Mr. Ferdinand Groenewald | Interim Chief Financial Officer & Principal Accounting Officer |
Mr. Frederick D. Hrkac | President, Principal Executive Officer, Executive Vice President & Director |
Dr. Budimir S. Drakulic Ph.D. | Chief Scientist |